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Background: Multidrug-resistant (MDR) Salmonella isolates are associated with increased morbidity compared to
antibiotic-sensitive strains and are an important health and safety concern in both humans and animals. Salmonella
enterica serovar Typhimurium is a prevalent cause of foodborne disease, and a considerable number of S.
Typhimurium isolates from humans and livestock are resistant to three or more antibiotics. The majority of these
MDR S. Typhimurium isolates are resistant to tetracycline, a commonly used and clinically and agriculturally relevant
antibiotic. Because exposure of drug-resistant bacteria to antibiotics can affect cellular processes associated with
virulence, such as invasion, we investigated the effect tetracycline had on the invasiveness of tetracycline-resistant
MDR S. Typhimurium isolates.
Results: The isolates selected and tested were from two common definitive phage types of S. Typhimurium, DT104
and DT193, and were resistant to tetracycline and at least three other antibiotics. Although Salmonella invasiveness
is temporally regulated and normally occurs during late-log growth phase, tetracycline exposure induced the full
invasive phenotype in a cell culture assay during early-log growth in several DT193 isolates. No changes in
invasiveness due to tetracycline exposure occurred in the DT104 isolates during early-log growth or in any of the
isolates during late-log growth. Real-time PCR was used to test expression of the virulence genes hilA, prgH, and
invF, and these genes were significantly up-regulated during early-log growth in most isolates due to tetracycline
exposure; however, increased virulence gene expression did not always correspond with increased invasion, and
therefore was not an accurate indicator of elevated invasiveness. This is the first report to assess DT193 isolates, as
well as the early-log growth phase, in response to tetracycline exposure, and it was the combination of both
parameters that was necessary to observe the induced invasion phenotype.
Conclusions: In this report, we demonstrate that the invasiveness of MDR S. Typhimurium can be modulated in
the presence of tetracycline, and this effect is dependent on growth phase, antibiotic concentration, and strain
background. Identifying the conditions necessary to establish an invasive phenotype is important to elucidate the
underlying factors associated with increased virulence of MDR Salmonella.
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Salmonella is the most common cause of bacterial
food-borne illness in the U.S. and is estimated to annually
cause over 1 million cases, 19,000 hospitalizations, 350
deaths, and $2.6 billion in social costs [1,2]. Salmonella
enterica serovar Typhimurium is one the most prevalent
salmonellae in humans and livestock, and many of these
cases are found to be resistant to multiple antibiotics.
According to the National Antimicrobial Resistance
Monitoring System (NARMS), 27-83% of S. Typhimurium
isolates from humans, chicken, cattle, and swine were
found to be resistant to three or more classes of antibiotics
[3]. A recent Salmonella Typhimurium isolate linked to an
outbreak associated with ground beef was resistant to eight
antibiotics: amoxicillin/clavulanic acid, ampicillin, ceftria-
xone, cefoxitin, kanamycin, streptomycin, sulfisoxazole, and
tetracycline [4].
Multidrug-resistant (MDR) Salmonella is associated with
increased morbidity in humans and increased mortality in
cattle relative to sensitive strains [5,6]. There are several
non-exclusive rationales for these clinical observations
[7,8]. One explanation is treatment failure, where the
administered antibiotic is ineffective due to bacterial
resistance, and therefore the infection persists and the
illness progresses. Another explanation is that the normal
gut flora is disrupted by an antibiotic regimen, thereby
increasing the risk of an opportunistic infection by drug-
resistant bacteria. Finally, there is the possibility that anti-
biotics can directly enhance bacterial virulence; this concept
is supported by several publications reporting that certain
antibiotics can alter virulence factors in some bacteria
in vitro [9-12], including tetracycline in S. Typhimurium
definitive phage type DT104 [13]. However, the report
by Weir et al. tested a single DT104 isolate at a single
tetracycline concentration during late-log growth and
identified a significant change in virulence gene ex-
pression, while an earlier report by Carlson et al. evalu-
ated over 400 DT104 isolates exposed to tetracycline
that were grown to stationary phase and did not observe
any isolates with a significantly increased ability to invade
cells in culture [14]. Resistance to tetracycline is prominent
among S. Typhimurium isolates in humans (34%), chickens
(39%), cattle (59%), and swine (88%) according to a ten-year
average from the National Antimicrobial Resistance
Monitoring System [3,15]; thus, our objective was to
explore the relationship between gene expression and
cellular invasion in response to tetracycline. We examined
the effects of sub-inhibitory tetracycline concentrations on
isolates of phage type DT104 and DT193 during early-log
and late-log growth to determine the conditions, if any,
that affect MDR Salmonella Typhimurium invasiveness
after tetracycline exposure. We ascertained that an induced-
invasion phenotype was a dose-dependent response due to
the combination of two novel study parameters, early-loggrowth and DT193 isolates. We also found that expression
of virulence genes can be tetracycline-induced during either
early-log or late-log growth in many isolates, but this did
not always correlate with increased invasiveness.
Results
Selection of isolates
A total of forty S. Typhimurium DT104 and DT193 isolates
from cattle were characterized for resistance to ampicillin,
chloramphenicol, gentamicin, kanamycin, streptomycin,
and tetracycline. Isolates resistant to tetracycline and at
least three additional antibiotics, but sensitive to gentami-
cin (which is needed to kill extracellular bacteria in the
invasion assays), were then screened for the presence
of the Salmonella genomic island 1 (SGI-1) and tetra-
cycline resistance genes known to occur in Salmonella
(tetA, B, C, D, and G). The SGI-1 is a 43 kb stable
chromosomal integron often found in DT104, and it
encodes several antibiotic resistance genes as well as
hypothetical genes that have a potential association
with virulence [16-18]. The SGI-1 was identified in all
DT104 isolates but in none of the DT193 isolates. All
the DT104 isolates encoded a single tetracycline resistance
gene, tetG, while the DT193 isolates encoded the following
combinations: tetA; tetA, B, C, and D; or tetB, C, and D.
Representatives of each tet-resistance gene combination
were selected at random for further study (Table 1).
Selection of antibiotic concentrations
Growth curves were determined for each of the eight isolates
over a range of tetracycline concentrations (0–256 μg/ml).
The growth curve for isolate 1434, which is representa-
tive of all the isolates, is shown in Figure 1. Tetracycline
concentrations between 1–128 μg/ml did not prevent
growth, and this range was considered sub-inhibitory for
this study. No significant change in growth due to antibiotic
addition was observed between 1–32 μg/ml of tetracycline.
Subsequent invasion and gene expression analyses were
performed using several concentrations of tetracycline
within this range (0, 1, 4, and 16 μg/ml) in order to assess if
an effect on invasion was concentration dependent.
Tetracycline induces invasion in a subset of isolates
during early-log phase
Regulation of the invasion process is initiated during
early-log phase of growth [19], and Salmonella becomes
fully invasive during the late-log phase [20]. Cellular
invasion assays were performed using isolates grown to
early-log phase (OD600 = 0.15) and exposed to 0, 1, 4,
and 16 μg/ml of tetracycline for 30 minutes to address
the effect tetracycline had on Salmonella invasiveness
(Figure 2A; Additional file 1). Three DT193 isolates
(1434, 5317, and 752) had a significant increase in inva-
sion during early-log growth in the presence of 16 μg/ml
Table 1 Characterization of antibiotic resistance profiles and tetracycline resistance genes in eight S. typhimurium isolates
Isolate Phagetype Resistance profile tet gene(s)
amp chlor gent kan strp tet tetA tetB tetC tetD tetG
1434 DT193 + + - + + + + - - - -
5317 DT193 + + - + + + + - - - -
752 DT193 + + - - + + + - - - -
1306 DT193 + + - + + + + + + + -
4584 DT193 + + - + + + - + + + -
530 DT104 + + - - + + - - - - +
290 DT104 + + - + + + - - - - +
360 DT104 + + - - + + - - - - +
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the presence of a single tetracycline resistance gene,
tetA (Table 1). Tetracycline exposure did not enhance
the invasion phenotype of the other DT193 isolates or
the three DT104 isolates.
To determine if tetracycline exposure enhances Salmonella
invasiveness during late-log phase, isolates were grown
to OD600 = 0.60 and exposed to 0, 1, 4, and 16 μg/ml of
tetracycline for 30 minutes. Tetracycline did not increase
the invasiveness of Salmonella during late-log growth in
any of the isolates (Figure 2B; Additional file 1). However,
the level of invasion induced by 16 μg/ml tetracycline dur-
ing early-log phase in the three DT193 isolates was similar
to the invasion levels of their respective controls (0 μg/ml)
during late-log phase. These results demonstrate that
when Salmonella is at its highest level of normal invasion
(late-log), exposure to sub-inhibitory levels of tetracycline
does not result in hyperinvasiveness; instead, tetracycline
exposure triggers the invasive phenotype in specific isolates
during a phase of growth that Salmonella is not otherwise
fully invasive (early-log).Figure 1 Representative growth curve of multidrug-resistant
S. Typhimurium exposed to various concentrations of
tetracycline. Serial two-fold dilutions of tetracycline (0–256 μg/ml)
were added at OD600 = 0.15 to each of the eight isolates to
determine the effect of tetracycline exposure on growth. The
growth curve of isolate 1434 is shown.Gene expression changes due to tetracycline exposure
The relative transcript levels of three genes associated
with invasion regulation (hilA, prgH, and invF), as well as
the tetracycline resistance genes in each isolate (tetA, B, C,
D, and/or G), were determined by real-time PCR. The hilA
gene is essential for invasion as HilA activity regulates
downstream invasion factors, which includes the prgH
and invF genes [21,22]. Together, these genes provide a
direct and indirect measure of both the hilA transcript
and HilA protein, respectively. During early-log phase,
all three invasion genes were significantly up-regulated
in seven of the eight isolates at 16 μg/ml compared to
the 0 μg/ml control, while four isolates had one or
more of the invasion genes significantly up-regulated
at 4 μg/ml; no invasion gene expression changes occurred
in any isolate at 1 μg/ml (Figure 3; Additional file 1).
The tetA, tetC, and tetD transcripts were significantly
up-regulated during early-log in their respective isolates
at all tetracycline concentrations (1, 4, and 16 μg/ml),
while tetG was only significantly up-regulated at 16 μg/ml.
No transcript was detected for tetB in the two isolates
that encoded this gene. The tetA, C, and D genes were
up-regulated at a concentration as low as 1 μg/ml tetracyc-
line, whereas increased invasion gene expression occurred
starting at 4 μg/ml, indicating changes in virulence factor
gene expression due to tetracycline is dose-dependent.
It should be noted that while 1 μg/ml is low for tetra-
cycline resistant strains of Salmonella, it is inhibitory
for sensitive strains.
During late-log phase, a significant increase in hilA,
prgH, and/or invF expression was observed in response
to tetracycline exposure in several isolates (Figure 3;
Additional file 1). The effect of tetracycline on the tet
genes was similar to the early-log data whereby tetA, C,
and D were up-regulated starting at 1 μg/ml, though none
of the tetG genes were up-regulated at this dose. Again,
an increase in virulence gene expression was dependent












































































Figure 2 Changes in S. Typhimurium invasiveness at early- and
late-log growth after tetracycline exposure. Invasion assays were
performed on S. Typhimurium isolates grown to either early- or
late-log phase and exposed to four different tetracycline
concentrations (0, 1, 4, and 16 μg/ml) for 30 minutes. Changes in
invasion were normalized to the control dose (0 μg/ml) for each
isolate at (A) early-log and (B) late-log growth phase. The “*”
indicates a significant change based on the pre-normalized data.
The numbers in parentheses indicate percent invasion at the control
dose (0 μg/ml) for each isolate.
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Multidrug-resistant Salmonella Typhimurium is a preva-
lent food safety and public health concern. Due to the
fact that tetracycline resistance is frequently found in
S. Typhimurium isolates from humans and livestock
[3,15], our goal was to test and characterize the con-
ditions necessary to generate an invasive phenotype
in MDR Salmonella following tetracycline exposure.
Two common MDR S. Typhimurium phage types are
DT104 and DT193, and these are typically resistant to three
or more antibiotics, are found in humans and livestock,and have been associated with foodborne outbreaks
[23-27]. DT104 and DT193 share a similar antibiotic
resistance profile, but the genetics underlying their
resistance phenotype differ. For instance, the majority
of resistance genes in DT104 isolates reside in the
Salmonella genomic island 1 on the chromosome, whereas
the resistance genes of DT193 are typically encoded on
plasmids. Also, DT104 isolates generally have only the
tetG gene to confer resistance to tetracycline, but iso-
lates of DT193 can have a combination of tetA-D genes
and usually lack tetG [28,29]. Since tetracycline is used
therapeutically in humans and animals, and because
most MDR S. Typhimurium isolates are resistant to
tetracycline, our goal was to determine the effect and
extent tetracycline exposure had on the invasiveness of
Salmonella isolates from DT104 and DT193. We examined
both cell culture invasion and virulence gene expression
in vitro in response to tetracycline under a combination
of three conditions: growth phase, tetracycline resistance
genotype, and antibiotic concentration.
Cellular invasion is a temporally-regulated process in
Salmonella that involves the activation of a sequence of
genes, most importantly, hilA [21]. The hilA gene is the
bottleneck in the process and its deletion prevents invasion
from occurring, whereas its over-expression usually results
in increased invasion [22]. The invasive response is initiated
during early-log growth, and Salmonella is considered max-
imally invasive during the late-log growth phase [20]. We
found that during early-log growth, tetracycline significantly
increased cellular invasion in three isolates, while it signifi-
cantly up-regulated the gene expression of virulence factors
hilA, prgH, and invF in seven isolates. None of the isolates
in the study had an increase in cellular invasion during
late-log growth in response to tetracycline, but expression
of virulence factors was up-regulated in several isolates.
The increased invasiveness of the isolates during early-log
was commensurate with the temporally-regulated invasive
phenotype observed in each respective 0 μg/ml control
isolate during late-log. Therefore, tetracycline exposure
induced a shift in the invasion response to an earlier
time in the growth cycle (early-log), yet tetracycline did
not enhance invasion efficacy when invasion was already
at its maximum potential in late-log growth. In addition,
an increase in virulence gene expression did not always
correlate with a reciprocal increase in invasion. The data
demonstrates that the induction of invasion by tetracycline
is a growth phase dependent response.
Several tetracycline concentrations were evaluated to
determine if invasion induction was dependent on dose,
or if the presence of tetracycline at any level would be
effective. Three concentrations of tetracycline that did not
inhibit growth of any of the isolates were chosen to study
(1, 4, 16 μg/ml). The tetracycline-induced invasion response
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Figure 3 Gene expression changes in S. Typhimurium at early- and late-log growth after tetracycline exposure. Real-time gene
expression assays were performed on S. Typhimurium isolates grown to either early- or late-log phase and exposed to four different tetracycline
concentrations (0, 1, 4, and 16 μg/ml) for 30 minutes. Virulence genes (hilA, prgH, and invF) and tetracycline resistance genes (tetA, B, C, D, and G)
were profiled. Compared to the control for each gene (0 μg/ml), black indicates no gene expression change, green indicates an increase in gene
expression, and red indicates a decrease in gene expression; the brighter the green or red, the greater the change. The white “*” denotes a
significant change in expression compared to the control.
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response.
DT104 and DT193 isolates that encode tetracycline
resistance genes commonly found in S. Typhimurium
(tetA, B, C, D, and G) were evaluated. The DT104 isolates
all had SGI-1 and tetG, but no other tetracycline resistance
genes were present. None of the DT193 isolates contained
SGI-1. Of the five DT193 isolates, three had only a tetA
gene, one had tetA, B, C, and D, and one had tetB, C,
and D. Only the three DT193 isolates encoding a single
tetracycline resistance gene, tetA, were more invasive
during early-log growth at 16 μg/ml of tetracycline; the
isolate that encoded tetA-D did not have this tetracycline-
induced phenotype. All isolates, except the isolate encod-
ing tetB-D (4584), had increased invasion gene expression
following tetracycline exposure during early-log phase.
Though a specific unknown mechanism that inducesinvasion in response to tetracycline may exist, it is not
shared by all isolates and is independent of SGI-1. In-
duction of invasion due to tetracycline exposure is re-
stricted to a subset of MDR S. Typhimurium isolates.
Previous work by Carlson et al. tested over 400 DT104
isolates that were exposed to tetracycline and grown to
stationary phase, but no difference in invasion due to
antibiotic treatment was observed [14]. Our data for the
DT104 and DT193 isolates grown to late-log phase and
then exposed to tetracycline are consistent with these re-
sults. Also, the increase in virulence gene expression dur-
ing late-log growth after tetracycline exposure reported by
Weir et al. [13] parallels our expression data. However, no
previous study examined the effect of any antibiotic on
DT193 or during early-log growth, and it was these two
factors that were critical to observing the induction of
the invasion phenotype due to tetracycline. The basis
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could be genetic content (e.g. the presence of additional
virulence genes), the differential regulation of a particular
response, or both.
Many studies have shown that antibiotics can directly
or indirectly effect transcription and regulation of cellular
processes [30-33]. In the current study, tetracycline up-
regulated genes associated with virulence, but this was
not always coincident with an increase in the invasive
phenotype. The regulation of invasion is a complex net-
work of interactions and responses, and it is possible that
the tetracycline stimulus could affect targets downstream of
hilA, invF, and prgH; such a response could up-regulate a
repressor of invasion in the non-induced isolates. Genome
sequencing of the isolates, plus transcriptomic analyses,
will provide a more complete picture of what genes and
processes are being affected by tetracycline exposure.
Evaluation of other antibiotics would also discern if the
response is specific to tetracycline, or if it is general to
an antibiotic stress.
The response to tetracycline by some MDR S.
Typhimurium isolates could provide a selective advantage
to the bacteria by quickly and efficiently promoting entry
into an intracellular niche within the host. Additionally,
the use of efflux pumps to maintain viability in the pre-
sence of tetracycline is an active transport mechanism that
requires energy to generate the proton gradient needed to
drive the antiporter [34]; escaping such an environment
would benefit the bacteria as fewer resources are required
in the absence of the antibiotic. MDR S. Typhimurium
already has a competitive advantage for survival due to its
antimicrobial resistance phenotypes compared to sensitive
strains, and our investigation identified an additional
advantage of a tetracycline-inducible invasion phenotype
that could influence colonization potential. Perhaps these
factors are associated with the increased morbidity ob-
served among MDR Salmonella patients.Table 2 Primers used for characterization and real-time PCR













We have found that tetracycline can induce invasion in
MDR S. Typhimurium, and that this response is dependent
on antibiotic concentration, growth phase, and isolate.
It does not appear that the induction of Salmonella
invasiveness is a universal phenotypic response, even
though the majority of isolates had an increase in virulence
gene expression; a significant increase in hilA gene ex-
pression was not an accurate indicator of increased cel-
lular invasion. Knowledge of the parameters necessary
to establish this phenotype is important to further elucidate




Forty isolates of Salmonella Typhimurium phage types
DT104 and DT193 originally collected from cattle were
selected at random for antibiotic-resistance characterization
from our NADC strain library. We defined drug-resistance
by the presence of growth after culturing all isolates on
separate LB plates overnight containing the following
antibiotics and concentrations: ampicillin (100 μg/ml),
chloramphenicol (30 μg/ml), gentamicin (100 μg/ml),
kanamycin (50 μg/ml), streptomycin (100 μg/ml), or
tetracycline (15 μg/ml). These cutoffs were adapted
based on studies and prior experience with Salmonella
grown in LB media [35-37], and all are near or above the
CLSI breakpoint concentrations for ampicillin (32 μg/ml),
chloramphenicol (32 μg/ml), gentamicin (16 μg/ml), kana-
mycin (64 μg/ml), streptomycin (64 μg/ml), and tetracycline
(16 μg/ml).
Characterization of tet resistance genes
Primers specific to tetA, B, C, D, and G genes were used
to identify the tetracycline resistance gene(s) present in













Brunelle et al. BMC Microbiology 2013, 13:202 Page 7 of 9
http://www.biomedcentral.com/1471-2180/13/202commonly observed in Salmonella [34]. Presence or absence
of the Salmonella genomic island 1 (SGI-1) was detected
with primers to the 5′ insertion site (thdF-S001), the internal
S013 gene, and the most 3′ SGI-1 gene, S044 (Table 2).
DNA was obtained by boiling a single colony from each
isolate in 30 μl water. Each 25 μL PCR reaction contained
1.5 μl DNA, 1.5 units of Taq polymerase (Promega),
1x PCR buffer with 1.5 mM MgCl2, 1 mM each dNTP,
and 0.8 μM of each primer. Amplification conditions
were: 94°C for 1 min; 35 cycles of 94°C for 30s, 56°C
for 30s, 72°C for 30s; 72°C for 2 min; 4°C hold. Ampli-
fications were done in duplicate, and amplicons were
visualized on 2% NuSieve gels (Cambrex, Rockland,
ME).
Culture conditions
For each experiment, Salmonella was plated on Lennox L
(LB) agar plates (Invitrogen, Carlsbad, CA), and a single
colony was selected and grown in LB broth with agitation
for 6 hours at 37°C. A 1:1000 dilution of the 6 hour cul-
ture was made in LB broth and grown with agitation at
37°C overnight. A 1:200 dilution of the overnight culture
was made in LB broth and divided into 16x100 glass tubes.
Depending on the assay, the cultures were grown to either
early-log (OD600 = 0.15) or late-log (OD600 = 0.6) with
agitation before tetracycline addition.
Growth curves
Growth curves for each isolate were determined by di-
luting overnight cultures 1:200, growing to early-log
phase (OD600 = 0.15), and adding serial dilutions of
tetracycline (0–256 μg/ml); this corresponds to the
early-log growth phase to be tested, and was necessary
to determine the effect of the antibiotic at this time
point. Cultures were shaken continuously, and growth
curve measurements (OD600) were taken every hour
for 24 hours using a Bioscreen C instrument (Growth
Curves LTD, Raisio, Finland). Differences between the
no-antibiotic control and the other sample conditions
during the logarithmic growth phase (0–9 hours) were
determined by a one-way ANOVA with Dunnett’s post-test
using GraphPad Prism 5 (GraphPad Software, San Diego,
CA). P values less than 0.05 were considered significant.
Experimental conditions
The effect of tetracycline during early-log growth phase
was examined using overnight cultures that were diluted
1:200 in LB, subcultured into four tubes, and grown to
OD600 = 0.15. An aliquot was taken for RNA analysis
from each culture and placed in RNAProtect (QIAGEN,
Germantown, MD). Tetracycline was then added to a
final concentration of 0 (control), 1, 4, and 16 μg/ml to
the four tubes for each isolate, and these were incubated
with agitation at 37°C for 30 min (final OD600 = ~0.30).Aliquots for RNA analysis were taken from each bacterial
culture and placed in RNAProtect. An additional aliquot
was taken from each culture for a cell culture invasion
assay. To test the effect of tetracycline during late-log
growth phase, each overnight culture was diluted 1:200 in
LB, split into four tubes, and grown to OD600 = 0.15. An
aliquot was taken for RNA analysis from each culture
and placed in RNAProtect. After these cultures grew to
OD600 = 0.60, tetracycline was added to a final concen-
tration of 0 (control), 1, 4, and 16 μg/ml to the four
tubes for each isolate and incubated with agitation at
37°C for 30 min (final OD600 = ~0.70). Aliquots for RNA
analysis were taken from each bacterial culture and
placed in RNAProtect. An additional aliquot was taken
from each culture for a cell culture invasion assay. All
experiments were performed four separate times.
Salmonella invasion assays
The aliquots taken following the 30 minute incubation with
and without tetracycline were centrifuged at 16,000 x g
for 2 minutes, and the pellets were re-suspended in
fresh LB broth to remove the antibiotic. Invasion assays
were performed with technical replicates for each bio-
logical replicate using a gentamicin protection assay in
HEp-2 cells at a multiplicity of infection of ~40 as pre-
viously described [41]. Percent invasion was calculated
by dividing CFU/ml recovered by CFU/ml added. The
significance of the differences in invasion were deter-
mined by a one-way repeated measures ANOVA with
Dunnett’s post-test to assess pair-wise differences bet-
ween the no-antibiotic control and the other sample
conditions using GraphPad Prism 5. P values less than
0.05 were considered significant. Each isolate had a dif-
ferent invasion rate without tetracycline, therefore inva-
sion at 1, 4, and 16 μg/ml tetracycline was normalized
to the control for each isolate at each growth phase for
graphical representation of the fold change; the com-
plete pre-normalized invasion data can be found in
Additional file 1.
Real-Time PCR assays
RNA was isolated using the RNeasy Mini Kit (QIAGEN,
Germantown, MD), and genomic DNA was removed using
the Turbo DNase DNA-free kit (Ambion, Austin, TX)
according to the directions from the manufacturers. Total
RNA was quantitated on a Nanodrop ND-1000 spectro-
photometer (Thermo Scientific, Wilmington, DE). Reverse
transcription was carried out using the Applied Biosystems
High capacity cDNA reverse transcription kit on total
RNA using random primers (Life Technologies, Grand
Island, NY), and technical replicates were performed for
each biological replicate. Real-Time PCR was performed in
a Bio-Rad CFX96 Real-Time PCR Detection System
(BioRad Laboratories, Hercules, CA) using the SYBR
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Primer sets were used to evaluate the 16S rRNA, hilA,
prgH, invF, tetA, tetB, tetC, tetD, and tetG transcripts
(Table 2). For control assays, reverse transcriptase was not
added to parallel mixtures for each sample. Amplifica-
tion was performed using the following cycle condi-
tions: 95°C for 10 min; 40 cycles of 95°C for 15 s, 55°C
for 30 s, 72°C for 30 s; melting curve analysis from 65°C
to 95°C. Raw data was analyzed using LinRegPCR soft-
ware, and amplification efficiencies and cycle threhhold
(CT) values were determined using a Window of Linea-
rity for each primer set [42]. Expression differences were




the 16S gene was the reference gene and the pre-antibiotic
sample was the control condition for each isolate at each
tetracycline concentration [43]. Values were log2 trans-
formed, and GraphPad Prism 5 was used to perform a one-
way repeated measures ANOVA with Dunnett’s post-test to
assess pair-wise differences between the no-antibiotic con-
trol and the other sample conditions. P values less than
0.05 were considered significant. A heat map was con-
structed to display the differences in the real-time data
relative to the control after tetracycline exposure; the
numerical real-time data can be found in Additional file 1.
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